» Articles » PMID: 32935628

Prolonged SARS-CoV-2 Detection and Reversed RT-PCR Results in Mild or Asymptomatic Patients

Overview
Publisher Informa Healthcare
Date 2020 Sep 16
PMID 32935628
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The clinical course and viral detection period in mild or asymptomatic coronavirus disease 2019 (COVID-19) patients are not yet known. The presumed low diagnostic sensitivity of upper respiratory specimens for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) makes it difficult to confirm infection and recommend de-isolation.

Methods: We retrospectively reviewed real-time reverse transcriptase-polymerase chain reaction (RT-PCR) test results of mild or asymptomatic COVID-19 patients who were admitted at the Daegu-Gyeongbuk 7th community treatment centre in Korea between 9 March 2020 and 10 April 2020. Patients underwent an upper respiratory RT-PCR test every week until discharge. From the RT-PCR results, we evaluated the rate of prolonged (>3 weeks) SARS-CoV-2 RNA positivity. We analysed the proportion of reversed results, defined as a positive or indeterminate result one day after a negative RT-PCR result, according to time (<14, 15-21, 22-28, >28 days) from the initial positive RT-PCR result.

Results: In 23% (69/300) of patients, SARS-CoV-2 was detected more than 3 weeks after the initial positive RT-PCR. In 14% (42/300) of patients, the RT-PCR results were positive for more than 4 weeks. For 37.5% (152/405) of negative RT-PCR results, the results were reversed in the next day's test. And 43.5% (123/283) of negative RT-PCR results were reversed within 3 weeks of diagnosis.

Conclusions: The detection of SARS-CoV-2 lasting more than 3 weeks was common in mild or asymptomatic patients. Upper respiratory RT-PCR results were frequently reversed from negative to positive.

Citing Articles

Association of clinical characteristics and vaccines with risk of persistently viral clearance in patients infected with SARS-CoV-2 Omicron variant in Shanghai, China.

Zhang W, Wu H, Guo Q, Xu X, Pu Y, Chen C Heliyon. 2024; 10(1):e23256.

PMID: 38192786 PMC: 10772582. DOI: 10.1016/j.heliyon.2023.e23256.


Risk Factors for Long COVID in Older Adults.

Hu Y, Liu Y, Zheng H, Liu L Biomedicines. 2023; 11(11).

PMID: 38002002 PMC: 10669899. DOI: 10.3390/biomedicines11113002.


Rapid antigen test as a tool for the identification of SARS-CoV-2 infection and its potential as a self-testing device.

Filgueiras P, Corsini C, Almeida N, Pedrosa M, de Miranda D, Gomes S Rev Soc Bras Med Trop. 2023; 56:e01672022.

PMID: 37222349 PMC: 10204152. DOI: 10.1590/0037-8682-0167-2022.


Persistence of SARS-CoV-2 RNA shedding and infectivity in immunized population: Prospective study along different epidemiological periods in Argentina.

Theaux C, Martin Y, Montoto Piazza L, Wenk G, Notaristefano G, Mino L PLoS One. 2023; 18(5):e0285704.

PMID: 37196044 PMC: 10191317. DOI: 10.1371/journal.pone.0285704.


SARS-CoV-2 viral load and shedding kinetics.

Puhach O, Meyer B, Eckerle I Nat Rev Microbiol. 2022; 21(3):147-161.

PMID: 36460930 PMC: 9716513. DOI: 10.1038/s41579-022-00822-w.